- 1
Your eSTAR section playbook
What FDA expects in each eSTAR section, and how to avoid the RTA cliff.
- 2
Hazard libraries that scale (ISO 14971)
Risk management you can reuse across devices instead of rebuilding from scratch.
- 3
Design controls under 21 CFR 820.30
The nine elements FDA reviews in your DHF, and the artifacts that prove each one.
- 4
Pre-Sub requests, done right
When a Q-Sub returns ROI, when it doesn't, and how to write one FDA actually answers.
- 5
Handling FDA AI letters and deficiency requests
Decode the request. Draft the response. Hit the clock.
- 6
Post-clearance changes & letter-to-file
When a modification needs a new 510(k), when a letter to file is enough, how to document the call.
You finished the RA Lead Track.
Want to keep going? Browse every explainer tagged for this track, or jump into another path.
Try another path
Founder Track
From device idea to documented FDA strategy
SaMD & AI Track
For software and AI/ML medical device teams navigating CDRH's evolving guidance
International Track
Enter the US market from abroad. The whole pathway, in plain English.
Post-Market Track
Your device is on the market. Stay compliant. Survive inspections. Avoid recalls.